Practice Management News

CHICAGO — Since its approval in 2020, Tepezza has become a go-to treatment for moderate to severe thyroid eye disease, unseating orbital decompression as the most used treatment, according to a presenter here.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Victor H. Gonzalez, MD, discusses VisionTEK Automation, an artificial intelligence tool that assists with practice billing and coding.

CHICAGO — In a study aimed at verifying the safety and efficacy of in-office oral sedation for oculofacial surgeries, patients and physicians who used an ASC said postoperatively they would have preferred to be in the office.

CHICAGO — Eliminating the use of opioids in the postoperative management of oculofacial surgery produced better pain control and subsequent patient satisfaction than standard of care regimens that included opioids, a presenter said here.

CHICAGO — Ophthalmologists should monitor patients with thyroid eye disease when they receive their COVID-19 vaccinations, according to a small case study presented at the ASOPRS Fall Scientific Symposium.

Often, after speaking about taxes at a medical conference, we are approached by a physician attendee who has read that billionaires, like Warren Buffet and Elon Musk, pay less taxes than they do and they wonder how that can be.

Emotional exhaustion has increased about 10% for all types of health care workers since the beginning of the COVID-19 pandemic, suggesting that current resources are not enough to improve their well-being, according to researchers.

Healio/OSN, in cooperation with Eyecelerator, recently conducted a survey of its ophthalmic audience to determine which newer technologies, therapies and treatments ophthalmologists are implementing.

In this episode, I share my preview of the hot topics for the upcoming AAO 2022 annual meeting, including my thoughts on ocular gene therapy and new treatments in the works.

MILAN — At OWL Connect during the ESCRS meeting, Nikki Sidi, vice president of global strategic marketing at Johnson & Johnson Vision, and Aylin Klç, MD, cataract and refractive surgery specialist in Istanbul, spoke about OWL’s mission.